{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:59:44Z","timestamp":1648576784074},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.mehy.2014.09.027","type":"journal-article","created":{"date-parts":[[2014,10,19]],"date-time":"2014-10-19T03:30:29Z","timestamp":1413689429000},"page":"726-729","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should we be more cautious about replacement of vitamin B12 in patients with cancer receiving cytotoxic chemotherapy?"],"prefix":"10.1016","volume":"83","author":[{"given":"Orhan Onder","family":"Eren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Akif","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem Uysal","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basak","family":"Oyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0005","first-page":"442","article-title":"Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999\u20132000","volume":"82","author":"Pfeiffer","year":"2005","journal-title":"Am J ClinNutr"},{"issue":"3","key":"10.1016\/j.mehy.2014.09.027_b0010","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcn\/86.3.718","article-title":"Trends in blood folate and vitamin B-12 concentrations in the United States, 1988\u20132004","volume":"86","author":"Pfeiffer","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ageing\/afg109","article-title":"Vitamin B12 and folate deficiency in later life","volume":"33","author":"Clarke","year":"2004","journal-title":"Age Ageing"},{"key":"10.1016\/j.mehy.2014.09.027_b0020","doi-asserted-by":"crossref","first-page":"209845","DOI":"10.1155\/2014\/209845","article-title":"A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde","volume":"2014","author":"Kwee","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0025","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2013.01.014","article-title":"Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms","volume":"1","author":"Kalyanaraman","year":"2013","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201102095","article-title":"Signal transduction by reactive oxygen species","volume":"194","author":"Finkel","year":"2011","journal-title":"J Cell Biol"},{"issue":"7\u20138","key":"10.1016\/j.mehy.2014.09.027_b0035","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.nut.2012.01.005","article-title":"Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes","volume":"28","author":"Al-Maskari","year":"2012","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.mehy.2014.09.027_b0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/01480545.2013.851686","article-title":"Evaluation of vitamin B12 effects on DNA damage induced by paclitaxel","volume":"37","author":"Alzoubi","year":"2014","journal-title":"Drug Chem Toxicol"},{"issue":"11","key":"10.1016\/j.mehy.2014.09.027_b0045","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/humu.21107","article-title":"Genetic and cellular studies of oxidative stress in methylmalonicaciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC)","volume":"30","author":"Richard","year":"2009","journal-title":"Hum Mutat"},{"issue":"42","key":"10.1016\/j.mehy.2014.09.027_b0050","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1021\/ja904670x","article-title":"Vitamin B(12) and redox homeostasis: cob(II)alamin reacts with superoxide at rates approaching superoxide dismutase (SOD)","volume":"131","author":"Suarez-Moreira","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.09.027_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mrgentox.2012.06.009","article-title":"Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone","volume":"748","author":"Alzoubi","year":"2012","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0060","first-page":"55","article-title":"Antigenotoxic efficacy of some vitamins against mutagenicity induced by ifosfamide mice","volume":"8","author":"Donya","year":"2010","journal-title":"Nat Sci"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainresrev.2008.05.001","article-title":"Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy","volume":"59","author":"Scalabrino","year":"2008","journal-title":"Brain Res Rev"},{"issue":"5","key":"10.1016\/j.mehy.2014.09.027_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.freeradbiomed.2006.05.014","article-title":"Tumor necrosis factor-alpha down-regulates human Cu\/Zn superoxide dismutase 1 promoter via JNK\/AP-1 signaling pathway","volume":"41","author":"Afonso","year":"2006","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.mehy.2014.09.027_b0075","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cmdc.200600308","article-title":"Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes","volume":"2","author":"Galletti","year":"2007","journal-title":"Chem Med Chem"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568009033333754","article-title":"Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation","volume":"3","author":"Yusuf","year":"2003","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0085","first-page":"130","article-title":"Raf-1\/bcl-2 phosphorylation: a step from microtubule damage to cell death","volume":"57","author":"Blagosklonny","year":"1997","journal-title":"Cancer Res"},{"issue":"46","key":"10.1016\/j.mehy.2014.09.027_b0090","doi-asserted-by":"crossref","first-page":"30777","DOI":"10.1074\/jbc.273.46.30777","article-title":"Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest","volume":"273","author":"Scatena","year":"1998","journal-title":"J Biol Chem"},{"issue":"43","key":"10.1016\/j.mehy.2014.09.027_b0095","doi-asserted-by":"crossref","first-page":"28253","DOI":"10.1074\/jbc.273.43.28253","article-title":"Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK\/SAPK)","volume":"273","author":"Lee","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/07357900009023060","article-title":"Role of taxanes in adjuvant therapy","volume":"18","author":"M\u00fcnster","year":"2000","journal-title":"Cancer Invest"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1054\/mehy.1999.0982","article-title":"A threshold concept for cancer therapy","volume":"55","author":"Kong","year":"2000","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.mehy.2014.09.027_b0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0891-5849(01)00616-5","article-title":"Direct effect of Taxol on free radical formation and mitochondrial permeability transition","volume":"31","author":"Varbiro","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.mehy.2014.09.027_b0115","first-page":"322","article-title":"Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells","volume":"54","author":"Wang","year":"2004","journal-title":"Cancer ChemotherPharmacol"},{"issue":"8","key":"10.1016\/j.mehy.2014.09.027_b0120","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-06-3914","article-title":"Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species","volume":"67","author":"Alexandre","year":"2007","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.mehy.2014.09.027_b0125","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1158\/0008-5472.CAN-05-1162","article-title":"Resistance to paclitaxel is proportional to cellular total antioxidant capacity","volume":"65","author":"Ramanathan","year":"2005","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.mehy.2014.09.027_b0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2007.01.005","article-title":"Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials","volume":"33","author":"Block","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.mehy.2014.09.027_b0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.mehy.2014.09.027_b0140","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Hardman","year":"1996"},{"key":"10.1016\/j.mehy.2014.09.027_b0145","first-page":"CD000951","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"5","author":"Shea","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.mehy.2014.09.027_b0150","doi-asserted-by":"crossref","first-page":"389046","DOI":"10.1155\/2013\/389046","article-title":"Effect of folic acid and vitamin B12 on pemetrexed antifolate chemotherapy in nutrient lung cancer cells","volume":"2013","author":"Yang","year":"2013","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.mehy.2014.09.027_b0155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1432-0436.2007.00238.x","article-title":"The epidermal growth factor receptor: from development to tumorigenesis","volume":"75","author":"Sibilia","year":"2007","journal-title":"Differentiation"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2011.05.046","article-title":"In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status","volume":"101","author":"Myllynen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.mehy.2014.09.027_b0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4757-3147-7_4","article-title":"The molecular and cellular biology of HER2\/neu gene amplification\/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer","volume":"103","author":"Pegram","year":"2000","journal-title":"Cancer Treat Res"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.09.027_b0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-010-0610-7","article-title":"Inhibition of ErbB2 by herceptin reduces viability and survival, induces apoptosis and oxidative stress in Calu-3 cell line","volume":"347","author":"Dogan","year":"2011","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2\u2032-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"issue":"9","key":"10.1016\/j.mehy.2014.09.027_b0180","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/carcin\/22.9.1459","article-title":"Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice","volume":"22","author":"Osterod","year":"2001","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2001.tb01041.x","article-title":"Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smoking","volume":"92","author":"Kasai","year":"2001","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1207\/s15327914nc5602_4","article-title":"Frequency of combined deficiencies of vitamin D and holotranscobalamin in cancer patients","volume":"56","author":"Plant","year":"2006","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.mehy.2014.09.027_b0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/03009730903027172","article-title":"Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer","volume":"114","author":"Bystr\u00f6m","year":"2009","journal-title":"Ups J Med Sci"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0200","first-page":"79","article-title":"Prevalence and aetiology of anaemia in lymphoid malignancies","volume":"26","author":"Ghosh","year":"2013","journal-title":"Natl Med J India"},{"issue":"4","key":"10.1016\/j.mehy.2014.09.027_b0205","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/cncr.20441","article-title":"Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review","volume":"101","author":"Baz","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.mehy.2014.09.027_b0210","first-page":"89","article-title":"Treatment of vitamin B12 deficiency. Evaluation of therapy with cyanocobalamin, hydroxocabalamin, and depot cobalamin Betolvex","volume":"29","author":"Bastrup-Madsen","year":"1974","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.mehy.2014.09.027_b0215","first-page":"CD004655","article-title":"Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency","volume":"3","author":"Vidal-Alaball","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0025-6196(12)61041-6","article-title":"Pernicious anemia revisited","volume":"69","author":"Pruthi","year":"1994","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0225","doi-asserted-by":"crossref","first-page":"313S","DOI":"10.3945\/ajcn.111.013243","article-title":"Biomarkers of vitamin B-12 status in NHANES: a roundtable summary","volume":"94","author":"Yetley","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2014.09.027_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ejh.12020","article-title":"Hypocupremia associated cytopenia and myelopathy: a national retrospective review","volume":"90","author":"Gabreyes","year":"2013","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00234-005-0016-5","article-title":"Imaging features of copper deficiency myelopathy: a study of 25 cases","volume":"48","author":"Kumar","year":"2006","journal-title":"Neuroradiology"},{"issue":"2","key":"10.1016\/j.mehy.2014.09.027_b0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MOG.0b013e3283505852","article-title":"Subclinical cobalamin deficiency","volume":"28","author":"Carmel","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.mehy.2014.09.027_b0245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1200\/JCO.2007.13.5905","article-title":"Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review","volume":"26","author":"Velicer","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714003533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714003533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T10:06:53Z","timestamp":1565950013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0306987714003533"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.09.027","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should we be more cautious about replacement of vitamin B12 in patients with cancer receiving cytotoxic chemotherapy?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}